Correlation Between Kiora Pharmaceuticals and Zura Bio
Can any of the company-specific risk be diversified away by investing in both Kiora Pharmaceuticals and Zura Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kiora Pharmaceuticals and Zura Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kiora Pharmaceuticals and Zura Bio Limited, you can compare the effects of market volatilities on Kiora Pharmaceuticals and Zura Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kiora Pharmaceuticals with a short position of Zura Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kiora Pharmaceuticals and Zura Bio.
Diversification Opportunities for Kiora Pharmaceuticals and Zura Bio
0.35 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Kiora and Zura is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding Kiora Pharmaceuticals and Zura Bio Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zura Bio Limited and Kiora Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kiora Pharmaceuticals are associated (or correlated) with Zura Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zura Bio Limited has no effect on the direction of Kiora Pharmaceuticals i.e., Kiora Pharmaceuticals and Zura Bio go up and down completely randomly.
Pair Corralation between Kiora Pharmaceuticals and Zura Bio
Given the investment horizon of 90 days Kiora Pharmaceuticals is expected to generate 1.09 times more return on investment than Zura Bio. However, Kiora Pharmaceuticals is 1.09 times more volatile than Zura Bio Limited. It trades about 0.01 of its potential returns per unit of risk. Zura Bio Limited is currently generating about -0.01 per unit of risk. If you would invest 465.00 in Kiora Pharmaceuticals on August 26, 2024 and sell it today you would lose (128.00) from holding Kiora Pharmaceuticals or give up 27.53% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Kiora Pharmaceuticals vs. Zura Bio Limited
Performance |
Timeline |
Kiora Pharmaceuticals |
Zura Bio Limited |
Kiora Pharmaceuticals and Zura Bio Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Kiora Pharmaceuticals and Zura Bio
The main advantage of trading using opposite Kiora Pharmaceuticals and Zura Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kiora Pharmaceuticals position performs unexpectedly, Zura Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zura Bio will offset losses from the drop in Zura Bio's long position.Kiora Pharmaceuticals vs. Virax Biolabs Group | Kiora Pharmaceuticals vs. Revelation Biosciences | Kiora Pharmaceuticals vs. Quoin Pharmaceuticals Ltd | Kiora Pharmaceuticals vs. Allarity Therapeutics |
Zura Bio vs. Eliem Therapeutics | Zura Bio vs. HCW Biologics | Zura Bio vs. Scpharmaceuticals | Zura Bio vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |